Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Early Detection of Cancer | 7 | 2025 | 414 | 2.190 |
Why?
|
| Neoplastic Syndromes, Hereditary | 5 | 2025 | 73 | 1.950 |
Why?
|
| von Hippel-Lindau Disease | 3 | 2025 | 20 | 1.670 |
Why?
|
| Paraganglioma | 2 | 2025 | 24 | 1.470 |
Why?
|
| Pheochromocytoma | 2 | 2025 | 38 | 1.460 |
Why?
|
| Adrenal Gland Neoplasms | 2 | 2025 | 79 | 1.390 |
Why?
|
| Jaw Neoplasms | 2 | 2025 | 6 | 1.090 |
Why?
|
| Multiple Endocrine Neoplasia | 2 | 2025 | 23 | 1.080 |
Why?
|
| Hyperparathyroidism | 2 | 2025 | 26 | 1.080 |
Why?
|
| Genetic Predisposition to Disease | 15 | 2025 | 3352 | 1.050 |
Why?
|
| Carney Complex | 1 | 2025 | 2 | 0.960 |
Why?
|
| Medulloblastoma | 6 | 2019 | 571 | 0.760 |
Why?
|
| Wilms Tumor | 4 | 2025 | 119 | 0.720 |
Why?
|
| Cerebellar Neoplasms | 6 | 2019 | 461 | 0.700 |
Why?
|
| Germ-Line Mutation | 6 | 2025 | 368 | 0.580 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 29 | 0.550 |
Why?
|
| Li-Fraumeni Syndrome | 1 | 2017 | 52 | 0.540 |
Why?
|
| Beckwith-Wiedemann Syndrome | 2 | 2024 | 16 | 0.430 |
Why?
|
| Child | 23 | 2025 | 25763 | 0.400 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 766 | 0.400 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2012 | 25 | 0.390 |
Why?
|
| Radiotherapy | 1 | 2012 | 145 | 0.360 |
Why?
|
| Palatal Neoplasms | 1 | 2011 | 5 | 0.360 |
Why?
|
| Hearing Loss | 2 | 2017 | 209 | 0.360 |
Why?
|
| Connexins | 1 | 2011 | 64 | 0.350 |
Why?
|
| Hepatoblastoma | 2 | 2024 | 183 | 0.300 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 2 | 2025 | 37 | 0.280 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2011 | 268 | 0.280 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 254 | 0.260 |
Why?
|
| DNA Methylation | 3 | 2019 | 1123 | 0.250 |
Why?
|
| Brain Neoplasms | 3 | 2024 | 1404 | 0.240 |
Why?
|
| Humans | 32 | 2025 | 132064 | 0.240 |
Why?
|
| Succinate Dehydrogenase | 1 | 2025 | 8 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2011 | 768 | 0.230 |
Why?
|
| Kidney Neoplasms | 3 | 2025 | 450 | 0.230 |
Why?
|
| Ribonuclease III | 2 | 2017 | 99 | 0.230 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2017 | 146 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 5 | 2025 | 1300 | 0.220 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2015 | 2850 | 0.220 |
Why?
|
| Adolescent | 12 | 2025 | 20542 | 0.210 |
Why?
|
| Retinoblastoma | 1 | 2025 | 112 | 0.210 |
Why?
|
| Mutation | 5 | 2020 | 6226 | 0.210 |
Why?
|
| Retinal Neoplasms | 1 | 2025 | 101 | 0.210 |
Why?
|
| Gadolinium | 1 | 2021 | 116 | 0.170 |
Why?
|
| DNA Polymerase II | 1 | 2019 | 20 | 0.160 |
Why?
|
| Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 29 | 0.160 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 86 | 0.150 |
Why?
|
| Cisplatin | 2 | 2017 | 280 | 0.150 |
Why?
|
| Neurofibroma, Plexiform | 1 | 2018 | 8 | 0.150 |
Why?
|
| Vascular Malformations | 1 | 2020 | 112 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 257 | 0.140 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 50 | 0.140 |
Why?
|
| Genotype | 4 | 2022 | 2697 | 0.140 |
Why?
|
| Neurofibromatosis 1 | 1 | 2018 | 66 | 0.140 |
Why?
|
| Fumarate Hydratase | 1 | 2017 | 3 | 0.140 |
Why?
|
| Leiomyomatosis | 1 | 2017 | 7 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-ret | 1 | 2017 | 35 | 0.140 |
Why?
|
| Hamartoma Syndrome, Multiple | 1 | 2017 | 20 | 0.130 |
Why?
|
| Antigens, Nuclear | 1 | 2017 | 56 | 0.130 |
Why?
|
| Child, Preschool | 10 | 2020 | 14734 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2017 | 56 | 0.130 |
Why?
|
| Fibroma | 1 | 2017 | 31 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 2020 | 251 | 0.130 |
Why?
|
| Sacroiliac Joint | 1 | 2016 | 4 | 0.130 |
Why?
|
| Neurofibrosarcoma | 1 | 2016 | 5 | 0.130 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 1 | 2016 | 19 | 0.130 |
Why?
|
| Sacrum | 1 | 2016 | 31 | 0.130 |
Why?
|
| Spinal Nerve Roots | 1 | 2016 | 19 | 0.130 |
Why?
|
| Pelvic Bones | 1 | 2016 | 28 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2024 | 1381 | 0.130 |
Why?
|
| Glioma | 1 | 2021 | 533 | 0.120 |
Why?
|
| Language Development Disorders | 1 | 2017 | 179 | 0.120 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 111 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 266 | 0.120 |
Why?
|
| Adenoma | 1 | 2017 | 146 | 0.120 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 295 | 0.120 |
Why?
|
| Ear Diseases | 1 | 2015 | 22 | 0.120 |
Why?
|
| Infant | 8 | 2023 | 13048 | 0.120 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 253 | 0.120 |
Why?
|
| Population Surveillance | 1 | 2017 | 416 | 0.110 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 176 | 0.110 |
Why?
|
| Microcephaly | 1 | 2017 | 351 | 0.110 |
Why?
|
| Pinealoma | 1 | 2014 | 22 | 0.110 |
Why?
|
| Pineal Gland | 1 | 2014 | 21 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2017 | 491 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 614 | 0.100 |
Why?
|
| Female | 13 | 2020 | 70664 | 0.100 |
Why?
|
| Young Adult | 5 | 2020 | 9952 | 0.100 |
Why?
|
| Colorectal Neoplasms | 1 | 2019 | 632 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 699 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2017 | 1017 | 0.100 |
Why?
|
| Neuroectodermal Tumors, Primitive | 1 | 2012 | 56 | 0.090 |
Why?
|
| Genetic Testing | 3 | 2025 | 1099 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 1957 | 0.090 |
Why?
|
| Male | 12 | 2020 | 64938 | 0.090 |
Why?
|
| Connexin 26 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1710 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2017 | 981 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 1 | 2017 | 1133 | 0.090 |
Why?
|
| Risk Factors | 4 | 2017 | 10938 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2010 | 64 | 0.080 |
Why?
|
| Carcinoma, Small Cell | 1 | 2010 | 42 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 2010 | 31 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2011 | 373 | 0.080 |
Why?
|
| Disease-Free Survival | 1 | 2012 | 956 | 0.080 |
Why?
|
| Thiolester Hydrolases | 1 | 2010 | 10 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2010 | 58 | 0.080 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 442 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 3842 | 0.080 |
Why?
|
| Skin Neoplasms | 1 | 2017 | 896 | 0.080 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2011 | 156 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2012 | 1127 | 0.080 |
Why?
|
| Chromosomes, Human, X | 1 | 2010 | 157 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2015 | 1580 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1668 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2017 | 2498 | 0.070 |
Why?
|
| NF-kappa B | 1 | 2010 | 454 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 2952 | 0.070 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 666 | 0.070 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2025 | 13 | 0.060 |
Why?
|
| DNA Mutational Analysis | 2 | 2019 | 823 | 0.060 |
Why?
|
| Phenotype | 3 | 2020 | 4527 | 0.060 |
Why?
|
| Australia | 1 | 2024 | 185 | 0.050 |
Why?
|
| Genetic Association Studies | 2 | 2018 | 852 | 0.050 |
Why?
|
| Adult | 3 | 2020 | 31571 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2003 | 153 | 0.050 |
Why?
|
| Fibroblast Growth Factors | 1 | 2003 | 166 | 0.050 |
Why?
|
| Patients | 1 | 2023 | 129 | 0.050 |
Why?
|
| Prognosis | 2 | 2020 | 5010 | 0.040 |
Why?
|
| DNA Mismatch Repair | 1 | 2019 | 54 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5412 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2019 | 249 | 0.040 |
Why?
|
| Germ Cells | 1 | 2019 | 204 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2017 | 5168 | 0.030 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 2017 | 4 | 0.030 |
Why?
|
| Retrospective Studies | 3 | 2021 | 17389 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 507 | 0.030 |
Why?
|
| Middle Aged | 1 | 2017 | 28993 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2019 | 363 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 117 | 0.030 |
Why?
|
| Larva | 1 | 2017 | 260 | 0.030 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 2017 | 97 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2017 | 1822 | 0.030 |
Why?
|
| Neutrophils | 1 | 2019 | 360 | 0.030 |
Why?
|
| Mass Screening | 1 | 2022 | 828 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2018 | 526 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 372 | 0.030 |
Why?
|
| Heterozygote | 1 | 2018 | 713 | 0.030 |
Why?
|
| Incidence | 1 | 2023 | 3375 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2017 | 244 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 343 | 0.030 |
Why?
|
| Infant, Newborn | 2 | 2020 | 8542 | 0.030 |
Why?
|
| Gene Editing | 1 | 2017 | 211 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 1457 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 417 | 0.030 |
Why?
|
| CRISPR-Cas Systems | 1 | 2017 | 294 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2019 | 1442 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2018 | 933 | 0.030 |
Why?
|
| Family Health | 1 | 2014 | 256 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1282 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 3043 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2019 | 1989 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 1683 | 0.020 |
Why?
|
| Yin-Yang | 1 | 2010 | 1 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2017 | 2509 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2010 | 172 | 0.020 |
Why?
|
| Brain | 1 | 2021 | 3181 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2015 | 3412 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2010 | 731 | 0.020 |
Why?
|
| Translocation, Genetic | 1 | 2010 | 357 | 0.020 |
Why?
|
| Texas | 1 | 2016 | 3627 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2010 | 435 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 679 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 1285 | 0.020 |
Why?
|
| Neurons | 1 | 2017 | 2002 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 2725 | 0.010 |
Why?
|
| Virus Inactivation | 1 | 2003 | 9 | 0.010 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 26 | 0.010 |
Why?
|
| Dactinomycin | 1 | 2003 | 49 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 71 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2003 | 118 | 0.010 |
Why?
|
| Bronchi | 1 | 2003 | 103 | 0.010 |
Why?
|
| United States | 1 | 2017 | 11660 | 0.010 |
Why?
|
| Cell Survival | 1 | 2003 | 866 | 0.010 |
Why?
|
| Virus Replication | 1 | 2003 | 636 | 0.010 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2003 | 377 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 905 | 0.010 |
Why?
|
| Animals | 1 | 2017 | 34804 | 0.010 |
Why?
|